← Eichor
Study identifier: NCT04595630 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Diagnostic and Prognostic Value of Cardiac Biomarkers for Early Coronary Bypass Occlusion in Patients Undergoing Coronary Revascularization

Condition: Coronary Bypass Graft Occlusion  ·  Sponsor: University Hospital, Basel, Switzerland

PhaseN/A
Planned participants480
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is to evaluate the correlation between hs-cTn level as cardiac biomarker for ischemia and early graft occlusion as assessed by CCT in patients undergoing coronary bypass surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Denis Berdajs, Prof. Dr. med.  ·  +41 61 328 71 80  ·  denis.berdajs@usb.ch

Always discuss trial participation with your own doctor first.

Locations (3)

University Hospital Centre ZagrebZagreb, CroatiaNot Yet Recruiting
Wroclaw Medical UniversityWroclaw, Borowska, PolandNot Yet Recruiting
Department for Cardiac Surgery, University Hospital BaselBasel, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04595630